Evaluation of AZD8154 concentrations in blood

Trial Identifier: D8900C00005
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04480879
Start Date: July 2020
Primary Completion Date: September 2020
Study Completion Date: September 2020
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050